Table 1.

Patients’ characteristics before therapy

	NYT	Control	P
Age (yr)	46.3 ± 14.3	54.9 ± 10.3	0.113
Gender (M/F)	9/1	8/5	0.123
Body weight (kg)	65.2 ± 9.8	60.6 ± 9.1	0.291
ALT (U/L)	74.9 ± 38.2	58.1 ± 25.1	0.457
Hb ( g/dL)	14.3 ± 1.4	14.0 ± 1.6	0.709
HCVRNA (kIU/mL)	553.5 ± 315.0	637.6 ± 314.0	0.673
HCV serotype (1/2)	8/2	9/4	0.377